ID   MLXPL_RAT               Reviewed;         865 AA.
AC   Q8VIP2;
DT   19-OCT-2011, integrated into UniProtKB/Swiss-Prot.
DT   01-MAR-2002, sequence version 1.
DT   24-JUL-2024, entry version 126.
DE   RecName: Full=Carbohydrate-responsive element-binding protein;
DE            Short=ChREBP;
DE   AltName: Full=Class D basic helix-loop-helix protein 14;
DE            Short=bHLHd14;
DE   AltName: Full=MLX interactor;
DE   AltName: Full=MLX-interacting protein-like;
DE   AltName: Full=WS basic-helix-loop-helix leucine zipper protein;
DE            Short=WS-bHLH;
DE   AltName: Full=Williams-Beuren syndrome chromosomal region 14 protein;
GN   Name=Mlxipl; Synonyms=Wbscr14;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], PHOSPHORYLATION AT SER-568, AND MUTAGENESIS OF
RP   SER-568.
RX   PubMed=11724780; DOI=10.1074/jbc.m107895200;
RA   Kawaguchi T., Osatomi K., Yamashita H., Kabashima T., Uyeda K.;
RT   "Mechanism for fatty acid 'sparing' effect on glucose-induced
RT   transcription: regulation of carbohydrate-responsive element-binding
RT   protein by AMP-activated protein kinase.";
RL   J. Biol. Chem. 277:3829-3835(2002).
RN   [2]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-23; SER-25; THR-27 AND
RP   SER-615, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22673903; DOI=10.1038/ncomms1871;
RA   Lundby A., Secher A., Lage K., Nordsborg N.B., Dmytriyev A., Lundby C.,
RA   Olsen J.V.;
RT   "Quantitative maps of protein phosphorylation sites across 14 different rat
RT   organs and tissues.";
RL   Nat. Commun. 3:876-876(2012).
CC   -!- FUNCTION: Transcriptional repressor. Binds to the canonical and non-
CC       canonical E box sequences 5'-CACGTG-3' (By similarity). {ECO:0000250}.
CC   -!- SUBUNIT: Binds DNA as a heterodimer with TCFL4/MLX. {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000255|PROSITE-ProRule:PRU00981}.
CC   -!- PTM: Phosphorylation at Ser-568 by AMPK inactivates the DNA-binding
CC       activity. {ECO:0000269|PubMed:11724780}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AB074517; BAB77523.1; -; mRNA.
DR   RefSeq; NP_598236.1; NM_133552.1.
DR   PDB; 5F74; X-ray; 2.35 A; B=1-196.
DR   PDBsum; 5F74; -.
DR   AlphaFoldDB; Q8VIP2; -.
DR   SMR; Q8VIP2; -.
DR   GlyGen; Q8VIP2; 1 site, 1 O-linked glycan (1 site).
DR   iPTMnet; Q8VIP2; -.
DR   PhosphoSitePlus; Q8VIP2; -.
DR   GeneID; 171078; -.
DR   KEGG; rno:171078; -.
DR   AGR; RGD:620400; -.
DR   CTD; 51085; -.
DR   RGD; 620400; Mlxipl.
DR   InParanoid; Q8VIP2; -.
DR   OrthoDB; 2963550at2759; -.
DR   PhylomeDB; Q8VIP2; -.
DR   Reactome; R-RNO-163358; PKA-mediated phosphorylation of key metabolic factors.
DR   EvolutionaryTrace; Q8VIP2; -.
DR   PRO; PR:Q8VIP2; -.
DR   Proteomes; UP000002494; Unplaced.
DR   GO; GO:0000785; C:chromatin; ISO:RGD.
DR   GO; GO:0005737; C:cytoplasm; ISO:RGD.
DR   GO; GO:0005829; C:cytosol; IDA:BHF-UCL.
DR   GO; GO:0005654; C:nucleoplasm; ISO:RGD.
DR   GO; GO:0005634; C:nucleus; IDA:BHF-UCL.
DR   GO; GO:0005667; C:transcription regulator complex; ISO:RGD.
DR   GO; GO:0035538; F:carbohydrate response element binding; NAS:BHF-UCL.
DR   GO; GO:0003677; F:DNA binding; IDA:UniProtKB.
DR   GO; GO:0001216; F:DNA-binding transcription activator activity; ISO:RGD.
DR   GO; GO:0001228; F:DNA-binding transcription activator activity, RNA polymerase II-specific; ISO:RGD.
DR   GO; GO:0003700; F:DNA-binding transcription factor activity; IDA:RGD.
DR   GO; GO:0000981; F:DNA-binding transcription factor activity, RNA polymerase II-specific; ISO:RGD.
DR   GO; GO:0140297; F:DNA-binding transcription factor binding; ISO:RGD.
DR   GO; GO:0001227; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; ISO:RGD.
DR   GO; GO:0046982; F:protein heterodimerization activity; ISO:RGD.
DR   GO; GO:0019901; F:protein kinase binding; IPI:UniProtKB.
DR   GO; GO:0000978; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; ISO:RGD.
DR   GO; GO:0061629; F:RNA polymerase II-specific DNA-binding transcription factor binding; ISO:RGD.
DR   GO; GO:0043565; F:sequence-specific DNA binding; IDA:RGD.
DR   GO; GO:0071333; P:cellular response to glucose stimulus; IDA:BHF-UCL.
DR   GO; GO:0097009; P:energy homeostasis; IMP:UniProtKB.
DR   GO; GO:0055089; P:fatty acid homeostasis; IMP:UniProtKB.
DR   GO; GO:0042593; P:glucose homeostasis; ISO:RGD.
DR   GO; GO:0010255; P:glucose mediated signaling pathway; ISO:RGD.
DR   GO; GO:0008610; P:lipid biosynthetic process; ISO:RGD.
DR   GO; GO:0045892; P:negative regulation of DNA-templated transcription; ISO:RGD.
DR   GO; GO:0090324; P:negative regulation of oxidative phosphorylation; ISO:RGD.
DR   GO; GO:0033137; P:negative regulation of peptidyl-serine phosphorylation; ISO:RGD.
DR   GO; GO:0000122; P:negative regulation of transcription by RNA polymerase II; ISO:RGD.
DR   GO; GO:0008284; P:positive regulation of cell population proliferation; ISO:RGD.
DR   GO; GO:0045893; P:positive regulation of DNA-templated transcription; ISO:RGD.
DR   GO; GO:0045723; P:positive regulation of fatty acid biosynthetic process; ISO:RGD.
DR   GO; GO:0045821; P:positive regulation of glycolytic process; ISO:RGD.
DR   GO; GO:0046889; P:positive regulation of lipid biosynthetic process; ISO:RGD.
DR   GO; GO:0045944; P:positive regulation of transcription by RNA polymerase II; ISO:RGD.
DR   GO; GO:0000432; P:positive regulation of transcription from RNA polymerase II promoter by glucose; ISO:RGD.
DR   GO; GO:0006110; P:regulation of glycolytic process; IDA:RGD.
DR   GO; GO:0006357; P:regulation of transcription by RNA polymerase II; IDA:RGD.
DR   GO; GO:0009749; P:response to glucose; IDA:RGD.
DR   GO; GO:0007584; P:response to nutrient; IEP:RGD.
DR   GO; GO:0031667; P:response to nutrient levels; IEP:RGD.
DR   GO; GO:0033552; P:response to vitamin B3; IEP:RGD.
DR   CDD; cd19689; bHLHzip_MLXIPL; 1.
DR   CDD; cd21771; NES2-NLS_ChREBP; 1.
DR   Gene3D; 4.10.280.10; Helix-loop-helix DNA-binding domain; 1.
DR   InterPro; IPR011598; bHLH_dom.
DR   InterPro; IPR036638; HLH_DNA-bd_sf.
DR   PANTHER; PTHR10328:SF12; CARBOHYDRATE-RESPONSIVE ELEMENT-BINDING PROTEIN; 1.
DR   PANTHER; PTHR10328; PROTEIN MAX MYC-ASSOCIATED FACTOR X; 1.
DR   Pfam; PF00010; HLH; 1.
DR   SMART; SM00353; HLH; 1.
DR   SUPFAM; SSF47459; HLH, helix-loop-helix DNA-binding domain; 1.
DR   PROSITE; PS50888; BHLH; 1.
PE   1: Evidence at protein level;
KW   3D-structure; DNA-binding; Nucleus; Phosphoprotein; Reference proteome;
KW   Repressor; Transcription; Transcription regulation.
FT   CHAIN           1..865
FT                   /note="Carbohydrate-responsive element-binding protein"
FT                   /id="PRO_0000413065"
FT   DOMAIN          662..716
FT                   /note="bHLH"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00981"
FT   REGION          15..41
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          53..77
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          334..392
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          500..653
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          716..737
FT                   /note="Leucine-zipper"
FT   COMPBIAS        342..375
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        517..539
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        579..602
FT                   /note="Pro residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        620..638
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOD_RES         20
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9NP71"
FT   MOD_RES         23
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         25
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         27
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         196
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9NP71"
FT   MOD_RES         568
FT                   /note="Phosphoserine; by AMPK"
FT                   /evidence="ECO:0000269|PubMed:11724780"
FT   MOD_RES         615
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         627
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9NP71"
FT   MOD_RES         644
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9NP71"
FT   MUTAGEN         568
FT                   /note="S->A: Impaired DNA-binding and fatty acid
FT                   sensitivity."
FT                   /evidence="ECO:0000269|PubMed:11724780"
FT   HELIX           118..134
FT                   /evidence="ECO:0007829|PDB:5F74"
SQ   SEQUENCE   865 AA;  94921 MW;  5B818B081B83C641 CRC64;
     MARALADLSV NLQVPRVVPS PDSDSDTDLE DPSPRRSAGG LHRSQVIHSG HFMVSSPHSD
     SLTRRRDQEG PVGLADFGPR SIDPTLTRLF ECLSLAYSGK LVSPKWKNFK GLKLLCRDKI
     RLNNAIWRAW YIQYVQRRKS PVCGFVTPLQ GSEADEHRKP EAVVLEGNYW KRRIEVVMRE
     YHKWRIYYKK RLRKSSREGD FLAPKQVEGG WPPPERWCEQ LFSSVVPVLL GGSEEEPGGR
     QLLDLDCFLS DISDTLFTMT QPSPSSLQLP SEDAYVGNAD MIQPDLTPLQ PSLDDFMEIS
     DFFTNYRPPQ TPTSSNFPEP PSFGPMADSL FSGGILGPEM PSPASASSSS GMTPLSGNTR
     LQARNSCSGP LDPSTFPSSE FLLPEDPKTK MPPAPVPTPL LPYPGPVKVH GLEPCTPSPF
     PTMAPPPALL SEEPLFSARF PFTTVPPAPG VSTLPAPTTF VPTPQPGPGP GPVPFPVDHL
     PHGYLEPVFG PHFTVPQGVQ PRCKPCSPPP GGRKASPPTL TSATASPTAT ATARDNNPCL
     TQLLRAAKPE QVLEPSTVPS TLLRPPESPD AVPEIPRVRA FYPPIPAPTP PRPPPGPATL
     APPRSLVVPK AERLSPPASS GSERRPSGDL NSIQPPGALS VHLSPPQTVL SRGRVDNNKM
     ENRRITHISA EQKRRFNIKL GFDTLHGLVS TLSAQPSLKV SKATTLQKTA EYILMLQQER
     AAMQEEAQQL RDEIEELNAA INLCQQQLPA TGVPITHQRF DQMRDMFDDY VRTRTLHNWK
     FWVFSILIRP LFESFNGMVS TASLHSLRQT SLAWLDQYCS LPALRPTVLN SLRQLSTSTS
     ILTDPSLVPE QATRAVTEGP LGRPL
//
